Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Shenzhen Kangtai Biological Pr (300601 CH)
Watchlist
65
Analysis
Health Care
•
China
Shenzhen Kangtai Biological Products Co., Ltd. operates biological product manufacturing businesses. The Company produces biological vaccines and other vaccine products. Shenzhen Kangtai Biological Products conducts businesses in China.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Jiangsu Hoperun Software
•
18 Aug 2024 10:54
Quiddity Leaderboard ChiNext & ChiNext 50 Dec 24: US$417mn One-Way; Some Changes to Expectations
We expect 8 changes for the ChiNext index and 5 changes for the ChiNext 50 index. Our latest estimates for one-way flows for ChiNext and ChiNext 50...
Janaghan Jeyakumar, CFA
Follow
549 Views
Share
bullish
•
Dbg Technology
•
17 Jul 2024 17:58
Quiddity Leaderboard ChiNext & ChiNext 50 Dec 24: Multiple Ranking Changes; Double-Impacts for Some
There could be US$474mn one-way flows collectively for the ChiNext and ChiNext 50 December 2024 index rebal events. We see 9 changes for ChiNext...
Janaghan Jeyakumar, CFA
Follow
474 Views
Share
bullish
•
Gambol Pet Group
•
24 Jun 2024 18:14
Quiddity Leaderboard ChiNext & ChiNext 50 Dec 24: Expected ADDs Could Outperform Expected DELs
We estimate one-way turnover to be US$343mn for the ChiNext index rebalance and US$130mn for the ChiNext 50 index rebalance in December 2024.
Janaghan Jeyakumar, CFA
Follow
435 Views
Share
bullish
•
Uber Technologies
•
03 Dec 2023 05:40
Index Rebalance & ETF Flow Recap: KWEB, CSI300/500, STAR50, SSE50, ChiNext, SET50, Chips, Denso, SPX
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
913 Views
Share
bullish
•
Zhongjin Gold Corp A
•
26 Nov 2023 11:00
CSI300 Index Rebalance: 14 Changes & A Few Surprises
There are 14 changes for the CSI300 in December. Most of the changes were expected and there are a few surprises as the index committee has...
Brian Freitas
Follow
1.3k Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x